Lung Cancer
Conference Coverage
Promising treatment option for incurable lung cancer described as ‘significant’
Investigators suggest this combo should be standard therapy for NSCLC going forward.
News
Some smokers don’t get lung cancer; genetics might explain it
These people have genes that help limit mutations to DNA that would turn cells malignant and make them grow into tumors.
News
Improved cancer survival in states with ACA Medicaid expansion
The 2-year overall survival increased from 80.6% before the ACA to 82.2% post ACA in expansion states and from 78.7% to 80% in nonexpansion states...
Original Research
Applicability of the USPSTF Lung Cancer Screening Guidelines in a Predominantly Black Veteran Population
This retrospective chart review examined the efficacy of the 2013 United States Preventive Services Task Force lung cancer screening guidelines in...
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
News
Fifth COVID shot recommended for patients with cancer
Conference Coverage
Preop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapy
The combination resulted in significantly longer event-free survival.
Conference Coverage
‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC
The finding comes from an analysis of long-term follow-up data from the CodeBreaK100 trial.
Conference Coverage
International group identifies actions to improve lung cancer survival
Experts recommend confirming lung cancer diagnosis within 30 days of referral.
Conference Coverage
Biomarker testing gains momentum in NSCLC
The NCCN recommends biomarker testing for patients with newly diagnosed stage 4 NSCLC.